Disruptive Thinking: What's Next for Pain

4:15 PM - 5:15 PM, Wednesday, June 10, 2020 ・ Room 11A
Initiatives to reduce opioid prescription and use are in force, but the need for effective pain relief, especially in areas like cancer, trauma and severe chronic pain, remains a pressing one. How can the biopharma industry develop and support the development of new analgesic drugs and other alternative treatments to pain? This panel will include perspectives on critical clinical needs, new avenues to novel non-addictive therapies, and the capital, public policies and regulations needed to advance non-opioid pain options to market. It’s on all of us to find new and effective treatments for pain because everyone in the healthcare industry is a stakeholder in the opioids crisis, a national public health emergency.